|
1714
|
(R)-(+)-SLV 319
|
Inactive enantiomer of SLV 319 |
€95.00
|
|
2367
|
AM 095 (parent compound)
|
Novel potent and selective LPA1 antagonist |
€125.00
|
|
1218
|
AM 251
|
CB1 antagonist |
€95.00
|
|
1219
|
AM 281
|
CB1 antagonist |
€95.00
|
|
2791
|
AM 4113
|
CB1 antagonist |
€105.00
|
|
3096
|
Amiselimod hydrochloride
|
S1PR modulator |
€105.00
|
|
3609
|
AS2717638
|
Highly potent, selective, orally active, and brain-penetrant LPA receptor 5 antagonist |
€180.00
|
|
3955
|
CB2R PAM C2
|
First synthetic, potent and orally active CB2 receptor PAM |
Recently added
|
€120.00
|
|
2015
|
CP 945598
|
CB1 antagonist |
€135.00
|
|
2119
|
CP 945598 hydrochloride
|
CB1 antagonist |
€135.00
|
|
3097
|
DBPR211
|
Potent and selective peripherally restricted CB1 antagonist/inverse agonist |
€125.00
|
|
1485
|
Fingolimod
|
S1PR1 agonist; Immunosuppressant |
€60.00
|
|
3632
|
Genistein
|
CB1 antagonist |
€70.00
|
|
1925
|
GW 842166X
|
Cannabinoid CB2 receptor agonist |
€110.00
|
|
1440
|
HU 308
|
CB2 agonist |
€140.00
|
|
1574
|
Iodopravadoline
|
CB2 antagonist |
€75.00
|
|
1866
|
JTE 013
|
S1PR2 antagonist |
€130.00
|
|
1418
|
JWH 133
|
CB2 agonist |
€110.00
|
|
1615
|
KRP 203
|
S1PR1 agonist |
Inquire
|
|
1550
|
MK 0364
|
CB1 antagonist/inverse agonist |
€95.00
|
|
1565
|
PSNCBAM 1
|
CB1 antagonist (allosteric) |
€85.00
|
|
1712
|
rac-(±)-SLV 319
|
Racemate of CB1 antagonist Ibipinabant (Axon 1713) |
€110.00
|
|
1947
|
RP 001 hydrochloride
|
A picomolar S1PR1 agonist |
€110.00
|
|
1672
|
SEW 2871
|
S1PR1 agonist |
€80.00
|
|
1713
|
SLV 319
|
CB1 antagonist |
€105.00
|
|
1220
|
SR 141716 hydrochloride
|
CB1 antagonist |
€70.00
|
|
1924
|
SR 144528
|
CB2 receptor antagonist and/or an inverse agonist |
€95.00
|
|
2404
|
TY 52156
|
Selective, competitive, and orally active S1P3 antagonist |
€110.00
|
|
3207
|
UCM-05194 ammonium salt
|
Potent and selective LPA1 receptor agonist |
€140.00
|
|
2543
|
ZCZ 011
|
Brain penetrant CB1 positive allosteric modulator (PAM) |
€90.00
|